Thrombocytosis affects the lungs by increasing the risk of pulmonary embolism and requires attention and symptomatic management.
There are two types of thrombocythemia: primary and secondary.
The most common comorbidities of primary thrombocythemia are thrombosis, such as cerebral thrombosis, lower extremity venous thrombosis, and in severe cases, cardiac infarction and pulmonary embolism.
Secondary thrombocytosis is associated with infections, tumors, and other factors, and resolution of the primary disease can improve the state of thrombocytosis.
Thrombocytosis increases the risk of embolism, and if the embolism occurs in the lungs, it can lead to pulmonary embolism, causing life-threatening respiratory and circulatory failure. Therefore, thrombocytosis should be treated aggressively to actively prevent embolism and avoid a serious adverse prognosis.